MarketWatch May 13, 2019
Meera Jagannathan

Why pharmaceutical manufacturers’ sky-high profits matter for consumers

Big Pharma eats up a lion’s share of health-care industry profits, according to new first-quarter financial reports — and its dominance has implications for Americans struggling to pay for prescription drugs.

More than half of total industry profits during that period went to the top 10 companies on the list, an Axios quarterly analysis showed. And 90% of those were drug manufacturers: Topping the list of highest-profiting companies were Eli LillyLLY, +0.50% at $4.2 billion, followed by Pfizer PFE, +0.22% at $3.9 billion and Johnson & Johnson JNJ, -0.28% at $3.7 billion.

“It’s not altogether surprising that this many [of the top 10] are pharmaceutical companies,” Stacie Dusetzina, an associate professor of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Pharma, Trends
How Will Walgreens’ Expansion into Specialty Pharmacy Affect the Industry?
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
Sanofi crosses Sjögren's off $5B drug's hit list after phase 2
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth

Share This Article